PATTABIRAMAN IYER: Open Payments
NPI 1083616817 · GUSTINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 14 payments from 6 companies in 2025. Trend: 2023 $180 · 2024 $219 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $80 |
| Amgen Inc. | 3 | $64 |
| PFIZER INC. | 3 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Abbott Laboratories | 1 | $28 |
| Alvogen Inc | 1 | $17 |
Products named: JARDIANCE, OTEZLA, NURTEC ODT, GEMTESA, FREESTYLE LIBRE 3, TERIPARATIDE, Repatha.
Industry payments across CA — which companies pay providers there.
